The risks of thrombolysis in patients without acute myocardial infarction

Thrombolysis for acute graft occlusion during elective endovascular aortic aneurysm repair

A 65-year-old man developed acute arterial thrombosis with stent graft occlusion, during elective endovascular aneurysm repair, with bilateral acute lower limb ischaemia. We describe successful endovascular and pharmacological management using a combination of mechanical disruption of the thrombus (using the access sheaths) followed by intra-arterial thrombolysis (Actilyse) infusion. Within 4-h the endograft had completely re-canalized. The patient made an uncomplicated recovery and was discharged on the second post-operative day.

Cardiac markers in the diagnosis of acute coronary syndromes

Evolution of the role of cardiac markers has ranged from the diagnosis of acute myocardial infarction in patients with nondiagnostic electrocardiograms to prognostic risk stratification and to guide therapy. The technology to provide rapid, real time measurements by immunoassay has provided the laboratory and clinician with a range of test options. The principal changes have been the use of rapid serial marker measurements of well-recognized cardiac markers, and the development of immunoassays for the cardiac structural proteins. Measurement of cardiac troponins has generated a new diagnostic paradigm in patients with suspected acute coronary syndromes. There is now a new gold standard biochemical test for myocardial infarction. A range of interventions can be guided by troponin measurement. The use of troponin measurements is central to management of patients with suspected acute coronary syndromes. Future developments in this field will focus on the role of existing and novel markers of inflammation and ischemia.

Value of the ECG in suspected acute myocardial infarction with left bundle branch block

Uncomplicated left bundle branch block (LBBB) is characterized by true ST-segment shifts resulting from delayed repolarization in the left ventricle with respect to the right ventricle. When acute coronary occlusions develop in the setting of previous or new LBBB, 12-lead eCG manifestations of injury may also appear. They consist of a more pronounced ST-segment elevation, of ST-segment deviations opposite to those of uncomplicated LBBB, or both. We have reported that the only 3 independent ECG signs of acute MI during LBBB among patients with chest pain or history of coronary disease are: ST elevation > or = 1 mm in leads with a positive QRS, ST-depression > or = 1 mm in V1 to V3, and ST elevation > or = 5 mm in leads with a negative QRS. In our study, the clinical prediction rule score values of these signs were 5; 3; and 2, respectively. A score > or = 3 made a diagnosis of MI with a 90% specificity and a score of 2 with > 80%, specificity. Recent validation studies have confirmed that the presence of any of these ECG signs is associated with a sensitivity of 44 to 79% and a specificity of 93 to 100%. Sensitivity increases if serial or previous ECGs are available for comparison. Interobserver agreement is very high. While current practice guidelines recommend thrombolysis for all patients with chest pain and LBBB, concern among physicians about hemorrhagic stroke prevents many of these patients from receiving timely treatment. In a population with LBBB and chest pain where our proposed ECG criteria were not ascertained, only 73% of eligible patients received thrombolysis; on the other hand, 48% of patients with no biochemical evidence of MI were thrombolyzed. For the latter group, the clinical prediction rule had a score of 0. Instead, 79% of patients with confirmed acute MI had a prediction rule score > or =2. Similar values applied to a subgroup of patients with serial ECGs. We propose that thrombolysis among patients with chest pain and LBBB be decided on the basis of a systematic ECG review to "rule patients in". This provision may result in both a significant reduction in the number of patients without infarction who receive thrombolysis and in timely treatment of those who do have MI.